LGND — LIGAND PHARMACEUTICALS INCToday's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.

Congress trades
9
all time
Members · 12m
1
4 buys · 0 sells · by trade date
Latest filing
06-08
2026-06-08
Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
2
13F holders
292
all listed · 2026-03-31
Congress: statutory ranges, filed up to 45 days after the trade · 13F: quarter-end snapshots, filed up to 45 days lateras of 2026-10-29
Congress 9Institutional 292

Congress · disclosure timeline

By trade date · 24 months · 4 rows ▲ buy, ▼ sell; height = lower bound (log scale). Trade date, not filing date — the filing lag is in the table below.

4 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds, against gridlines at $15K, $250K, $5M.

Members active in LGND

12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).
Members disclosing LGND in the trailing 12 months
MemberRowsNet disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point.Number of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join.
Gilbert Ray Cisneros, Jr. D–CA-314$4.0K to $60.0K2

1 member

Congressional disclosures

Newest filed firstAll 9 rows ↗
Latest congressional filings mentioning LGND
FiledMemberSide · OwnerTraded · LagAmountRange · FlagsSrc
2026-06-08Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 05-29 +10d$1K–$15K
2026-04-07Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 03-03 +35d$1K–$15K
2026-02-13Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 01-15 +29d$1K–$15K
2026-02-13Gilbert Ray Cisneros, Jr. D–CA-31BUYTraded 01-05 +39d$1K–$15K
2020-12-03Katherine M. Clark D–MA-5SELL SP (spouse-owned)Traded 10-22 +42d$1K–$15K
2020-12-03Katherine M. Clark D–MA-5SELL SP (spouse-owned)Traded 10-22 +42d$1K–$15K
2020-05-29Katherine M. Clark D–MA-5BUY SP (spouse-owned)Traded 04-03 LATE·56d$1K–$15K
2020-05-29Katherine M. Clark D–MA-5BUY SP (spouse-owned)Traded 04-03 LATE·56d$1K–$15K
2018-01-09Lamar Smith R–TX-21BUYTraded 2017-12-01 +39d$1K–$15K

13F holders · Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt. · longs only

Top institutional holders of LGND for quarter 2026-03-31, 1–25 of 292 holders
#FilerValueSecuritiesFlagsderived by Public Filings from this build's reviewed ticker-mapping holders list for this share class; that list carries each holder's share count, share change and filed date, which this table does not show, but no document links — the EDGAR link opens the filer's 13F list·§
1BlackRock, Inc.$591M1
derived ·§ EDGAR ↗
2VANGUARD PORTFOLIO MANAGEMENT LLC$220M1
derived ·§ EDGAR ↗
3Janus Henderson Group Ltd.$202M1
derived ·§ EDGAR ↗
4VANGUARD CAPITAL MANAGEMENT LLC$169M1
derived ·§ EDGAR ↗
5Invesco Ltd.$164M1
derived ·§ EDGAR ↗
6STATE STREET CORP$155M1
derived ·§ EDGAR ↗
7FMR LLC$119M1
derived ·§ EDGAR ↗
8NOMURA ASSET MANAGEMENT INTERNATIONAL INC.$114M1
derived ·§ EDGAR ↗
9FRANKLIN RESOURCES INC$114M1
derived ·§ EDGAR ↗
10Chicago Capital, LLC$112M1
derived ·§ EDGAR ↗
11GEODE CAPITAL MANAGEMENT, LLC$112M1
derived ·§ EDGAR ↗
12Stephens Investment Management Group LLC$98.8M1
derived ·§ EDGAR ↗
13DIMENSIONAL FUND ADVISORS LP$84.9M1
derived ·§ EDGAR ↗
14MASSACHUSETTS FINANCIAL SERVICES CO /MA/$82.2M1
derived ·§ EDGAR ↗
15DEUTSCHE BANK AG\$61.1M1
derived ·§ EDGAR ↗
16RICE HALL JAMES & ASSOCIATES, LLC$56.6M1
derived ·§ EDGAR ↗
17NORTHERN TRUST CORP$50.7M1
derived ·§ EDGAR ↗
18UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC$42.5M1
derived ·§ EDGAR ↗
19VILLERE ST DENIS J & CO LLC$37.7M1
derived ·§ EDGAR ↗
20CHARLES SCHWAB INVESTMENT MANAGEMENT INC$36.5M1
derived ·§ EDGAR ↗
21MORGAN STANLEY$33.4M1
derived ·§ EDGAR ↗
22BANK OF AMERICA CORP /DE/$31.5M1
derived ·§ EDGAR ↗
23Fiera Capital Corp$27.0M1
derived ·§ EDGAR ↗
24VANGUARD FIDUCIARY TRUST CO$25.5M1
derived ·§ EDGAR ↗
25NOMURA HOLDINGS INC$22.8M1
derived ·§ EDGAR ↗
Show all 292 holders
Truncated by Public Filings. All 247 13F filers reporting this share class are listed. Method ↗

Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.

Congress ↔ notable managers · LGND

Congress · last 90 days

Buyers
0 — —
Sellers
0 — —

filed 2026-07-31 → 2026-10-29 · statutory ranges

Notable managers · quarter ended 2026-03-31

Adding
1 Caxton Associates $3.7M held

by shares · $ = value heldNEW + ADD vs TRIM + EXIT, by share count. $ = reported value now, not the change. · LIGAND PHARMACEUTICALS INC

Merged timeline of congressional filings and notable-manager moves on LGND
DateWhoChangeSize
2026-05-15Gotham Asset Management 13FTRIM−5,174 sh
2026-05-15Bridgewater Associates 13FEXIT−4,207 sh
2026-05-14Caxton Associates 13FADD+4,143 sh

3 newest, by filing date · 13F rows are quarter-end snapshots, not trades

Congress vs filers

12 months
Congress net (rows)4 buy / 0 sell
Congress net ($ bound)$4.0K to $60.0K
Filersnot computedThe filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.